Carnegie Investment Counsel’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,204
Closed -$272K 504
2023
Q1
$272K Buy
1,204
+52
+5% +$10.6K 0.01% 449
2022
Q4
$227K Sell
1,152
-339
-23% -$70.3K 0.01% 465
2022
Q3
$277K Buy
1,491
+149
+11% +$29.5K 0.01% 411
2022
Q2
$241K Buy
1,342
+270
+25% +$68.9K 0.01% 430
2022
Q1
$364K Buy
1,072
+36
+3% +$12.2K 0.01% 386
2021
Q4
$383K Buy
1,036
+349
+51% +$132K 0.01% 385
2021
Q3
$271K Buy
687
+52
+8% +$23.9K 0.01% 409
2021
Q2
$292K Buy
635
+34
+6% +$13.7K 0.01% 399
2021
Q1
$225K Hold
601
0.01% 420
2020
Q4
$216K Buy
+601
New +$192K 0.01% 403
2020
Q3
Sell
-591
Closed -$213K 416
2020
Q2
$213K Buy
+591
New +$190K 0.01% 388
2019
Q4
Sell
-797
Closed -$236K 430
2019
Q3
$236K Buy
+797
New +$235K 0.02% 381

Other funds holding ILMN

Carnegie Investment Counsel's ILMN Position: Q2 2023 in Review

Carnegie Investment Counsel sold out of Illumina (ILMN) in Q2 2023, closing a stake of 1,204 shares — an estimated $272K sold.

Carnegie Investment Counsel first reported a position in ILMN in Q3 2019 and held it in 12 quarters. The position peaked at $383K in Q4 2021. 895 funds tracked by Wall St. Rank hold ILMN as of Q2 2023.

  • Carnegie Investment Counsel reported no remaining Illumina position as of Q2 2023 after selling out during the quarter.
  • Carnegie Investment Counsel sold 1,204 Illumina shares in Q2 2023, an estimated $272K.
  • Carnegie Investment Counsel first reported a position in Illumina in Q3 2019 and held it in 12 quarters.
  • Carnegie Investment Counsel's Illumina position peaked at $383K in Q4 2021.
  • 895 funds tracked by Wall St. Rank held Illumina as of Q2 2023.

Based on Carnegie Investment Counsel's 13F filing for Q2 2023, filed 4 Aug 2023.